Ibrutinib,Obinutuzumab,Venetoclax
Abbvie,Roche
['a041702', 'cll', 'vela,(-revelation),(-revelations)', 'vela']
 asco 2023 dr. #brianhillmdphd, from #clevelandclinic, reveals insights at #asco23 from the #a041702 study. this phase 3 trial compared different regimens for previously untreated #cll patients over 70. 
Produce, Find, and Distribute the latest and highest quality  multimedia to oncologists, hematologists and researchers.